EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Low-dose lithium adjunct to quetiapine improves cognitive task performance in mice with MK801-induced long-term cognitive impairment: Evidence from a pilot study

Chuanjun Zhuo, Hongjun Tian, Jingjing Zhu, Tao Fang, Jing Ping, Lina Wang, Yun Sun, Langlang Cheng, Chunmian Chen, Guangdong Chen

Journal of Affective Disorders · 2023

DOI: 10.1016/j.jad.2023.07.104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2023. Verfasst von Chuanjun Zhuo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Sensory Information Processing Abnormalities in Schizophrenia (SIPAC_Lab), Tianjin Fourth Center Hospital, Nankai University Affili…. Hauptthemen laut MEDLINE: Lithium, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Low-dose lithium (LD-Li) has been shown to rescue cognitive impairment in mouse models of short-term mild cognitive impairment, dementia, and schizophrenia. However, few studies have characterized the effects of LD-Li, alone or in conjunction with anti-psychotics, in the mouse model of MK801-induced long term cognitive impairment. METHODS: The present study used in vivo Ca2+ imaging and a battery of cognitive function assessments to investigate the long-term effects of LD-Li on cognition in mice exposed to repeated injections of MK801. Prefrontal Ca2+ activity was visualized to estimate alterations in neural activity in the model mice. Pre-pulse inhibition (PPI), novel object recognition (NOR), Morris water maze (MWM), and fear conditioning (FC) tasks were used to characterize cognitive performance; open field activity (OFA) testing was used to observe psychotic symptoms. Two treatment strategies were tested: LD-Li [250 mg/d human equivalent dose (HED)] adjunct to quetiapine (QTP; 600 mg/d HED); and QTP-monotherapy (mt; 600 mg/d HED). RESULTS: Compared to the QTP-mt group, the LD-Li + QTP group showed greatly improved cognitive performance on all measures between experimental days 29 and 85. QTP-mt improved behavioral measures compared to untreated controls, but the effects persisted only from day 29 to day 43. These data suggest that LD-Li + QTP is superior to QTP-mt for improving long-term cognitive impairments in the MK801 mouse model. LIMITATIONS: There is no medical consensus regarding lithium use in patients with schizophrenia. CONCLUSION: More pre-clinical and clinical studies are needed to further investigate effective treatment strategies for patients with long-term cognitive impairments, such as chronic schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LithiumCognitive DysfunctionHumansMiceAnimalsQuetiapine FumarateDizocilpine MaleatePilot ProjectsTask Performance and AnalysisCognitionDisease Models, Animal

Stichwörter der Autor:innen

CognitionLithiumMice modelQuetiapineSchizophrenia

Substanzen

Quetiapine FumarateLithiumDizocilpine Maleate

Autor:innen und Institutionen

  • Key Laboratory of Sensory Information Processing Abnormalities in Schizophrenia (SIPAC_Lab), Tianjin Fourth Center Hospital, Nankai University Affiliated Tianjin Fourth Center Hospital, Tianjin Medical University Affili…
  • Animal Imaging Center (AIC), Wenzhou Seventh Peoples Hospital, Wenzhou 325000, China.
  • Laboratory of Psychiatric-Neuroimaging-Genetic and Co-morbidity (PNGC_Lab), Tianjn Anding Hospital, Nankai University Affiliated Tianjin Anding Hospital, Tianjin Mental Health Center of Tianjin Medical University, Tianj…

Zitieren

APA

Zhuo, C., Tian, H., Zhu, J., Fang, T., Ping, J., Wang, L., Sun, Y., Cheng, L., Chen, C., & Chen, G. (2023). Low-dose lithium adjunct to quetiapine improves cognitive task performance in mice with MK801-induced long-term cognitive impairment: Evidence from a pilot study. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2023.07.104

Vancouver

Zhuo C, Tian H, Zhu J, Fang T, Ping J, Wang L, et al. Low-dose lithium adjunct to quetiapine improves cognitive task performance in mice with MK801-induced long-term cognitive impairment: Evidence from a pilot study. Journal of Affective Disorders. 2023. doi:10.1016/j.jad.2023.07.104

BibTeX
@article{Zhuo2023,
  author = {Zhuo, Chuanjun and Tian, Hongjun and Zhu, Jingjing and Fang, Tao and Ping, Jing and Wang, Lina and Sun, Yun and Cheng, Langlang and Chen, Chunmian and Chen, Guangdong},
  title = {Low-dose lithium adjunct to quetiapine improves cognitive task performance in mice with MK801-induced long-term cognitive impairment: Evidence from a pilot study},
  journal = {Journal of Affective Disorders},
  year = {2023},
  doi = {10.1016/j.jad.2023.07.104}
}
Kostenlos starten →